- Home
- TLSI vs NNBR Comparison
TLSI vs NNBR Comparison
Compare TLSI & NNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- NNBR
- Stock Information
- Founded
- TLSI 2010
- NNBR 1980
- Country
- TLSI United States
- NNBR United States
- Employees
- TLSI N/A
- NNBR N/A
- Industry
- TLSI Medical Specialities
- NNBR Industrial Machinery/Components
- Sector
- TLSI Health Care
- NNBR Industrials
- Exchange
- TLSI Nasdaq
- NNBR Nasdaq
- Market Cap
- TLSI 158.0M
- NNBR 173.8M
- IPO Year
- TLSI N/A
- NNBR 1994
- Fundamental
- Price
- TLSI $5.77
- NNBR $2.89
- Analyst Decision
- TLSI Strong Buy
- NNBR
- Analyst Count
- TLSI 6
- NNBR 0
- Target Price
- TLSI $11.75
- NNBR N/A
- AVG Volume (30 Days)
- TLSI 40.4K
- NNBR 228.9K
- Earning Date
- TLSI 03-27-2025
- NNBR 03-10-2025
- Dividend Yield
- TLSI N/A
- NNBR N/A
- EPS Growth
- TLSI N/A
- NNBR N/A
- EPS
- TLSI N/A
- NNBR N/A
- Revenue
- TLSI $26,891,000.00
- NNBR $470,310,000.00
- Revenue This Year
- TLSI $61.29
- NNBR N/A
- Revenue Next Year
- TLSI $53.21
- NNBR $0.69
- P/E Ratio
- TLSI N/A
- NNBR N/A
- Revenue Growth
- TLSI 67.90
- NNBR N/A
- 52 Week Low
- TLSI $3.50
- NNBR $2.38
- 52 Week High
- TLSI $10.42
- NNBR $5.20
- Technical
- Relative Strength Index (RSI)
- TLSI 68.94
- NNBR 41.16
- Support Level
- TLSI $5.40
- NNBR $3.12
- Resistance Level
- TLSI $5.82
- NNBR $3.52
- Average True Range (ATR)
- TLSI 0.24
- NNBR 0.20
- MACD
- TLSI 0.01
- NNBR -0.01
- Stochastic Oscillator
- TLSI 89.19
- NNBR 1.56
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About NNBR NN Inc.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets. It also operates in China, Mexico, Brazil, Germany, and other countries.